Show simple item record

dc.contributor.authorSedky, Nada K.
dc.contributor.authorBraoudaki, Maria
dc.contributor.authorMahdy, Noha Khalil
dc.contributor.authorAmin, Kenzy
dc.contributor.authorFawzy, Iten M.
dc.contributor.authorEfthimiadou, Eleni K.
dc.contributor.authorYouness, Rana A.
dc.contributor.authorFahmy, Sherif Ashraf
dc.date.accessioned2023-09-27T20:15:00Z
dc.date.available2023-09-27T20:15:00Z
dc.date.issued2023-09-15
dc.identifier.citationSedky , N K , Braoudaki , M , Mahdy , N K , Amin , K , Fawzy , I M , Efthimiadou , E K , Youness , R A & Fahmy , S A 2023 , ' Box–Behnken design of thermo-responsive nano-liposomes loaded with a platinum( iv ) anticancer complex: evaluation of cytotoxicity and apoptotic pathways in triple negative breast cancer cells † ' , Nanoscale Advances , vol. 5 , no. 19 , pp. 5399–5413 . https://doi.org/10.1039/d3na00368j
dc.identifier.otherJisc: 1341075
dc.identifier.otherpublisher-id: d3na00368j
dc.identifier.urihttp://hdl.handle.net/2299/26777
dc.description© 2023 The Author(s). Published by the Royal Society of Chemistry. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC), https://creativecommons.org/licenses/by-nc/4.0/
dc.description.abstractHerein, thermo-responsive liposomes (TLs) loaded with Asp (Asp/TLs) were produced by self-assembling DPPC, DSPE-PEG2000, and cholesterol. The preparation variables were optimized using the Box–Behnken design (BBD). The optimized Asp/TLs exhibited an average particle size of 114.05 ± 1.56 nm, PDI of 0.15 ± 0.015, zeta potential of −15.24 ± 0.65 mV, and entrapment efficiency (EE%) of 84.08 ± 2.75%. In addition, under physiological conditions, Asp/TLs showed spherical shape, outstanding stability and thermo-triggered the release of Asp at 38 °C, reaching the maximum Asp release at 40 °C. The MTT assay showed that the optimal Asp/TLs exhibited the highest cytotoxic activity upon exposure to mild hyperthermia (40 °C) against the invasive triple-negative breast cancer cell line (MDA-MB-231) when compared to other preparations. The IC50 of Asp/TLs (40 °C) was estimated at 0.9 μg mL−1, while that of free Asp (40 °C) was 3.83 μg mL−1. As such, the optimal Asp/TLs were shown to increase the cytotoxic activity of Asp by 4-fold upon exposure to mild hyperthermia. The IC50 values of Asp and Asp/TLs without exposure to 40 °C were 6.6 μg mL−1 and 186 μg mL−1, respectively. This indicated that Asp was released only when placed at 40 °C. The apoptosis assay revealed that Asp/TLs (40 °C) caused a remarkable increase in the percentage of cell population among both the late apoptosis and necrosis quartiles, as well as a significant decline in the viable cell quartile (P ≤ 0.001) when compared to Asp (40 °C). Asp/TLs (40 °C) and Asp (40 °C) could stimulate the intrinsic apoptosis pathway by upregulating the apoptotic genes Bak and Bax, while downregulating the anti-apoptotic genes, BCL-xL and BCL-2. The free Asp (40 °C) increased the gene expression of Bak and Bax by 4.4- and 5.2-folds, while reducing the expression of BCL-xL and BCL-2 by 50% and 73%, respectively. The optimal Asp TLs (40 °C) manifested more potent effects as demonstrated by the upregulation of Bak, Bax, and P53 by 5.6-, 7.2-, and 1.3-folds, as well as the downregulation of BCL-xL and BCL-2 by 70% and 85%, respectively. As such, the optimal Asp TLs (40 °C) treatment displayed the most potent cytotoxic profile and induced both apoptosis and necrosis in MDA-MB-231.en
dc.format.extent15
dc.format.extent3225255
dc.language.isoeng
dc.relation.ispartofNanoscale Advances
dc.titleBox–Behnken design of thermo-responsive nano-liposomes loaded with a platinum( iv ) anticancer complex: evaluation of cytotoxicity and apoptotic pathways in triple negative breast cancer cells †en
dc.contributor.institutionCentre for Future Societies Research
dc.contributor.institutionDepartment of Clinical, Pharmaceutical and Biological Science
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionBiosciences Research Group
dc.contributor.institutionCentre for Research in Mechanisms of Disease and Drug Discovery
dc.description.statusPeer reviewed
rioxxterms.versionofrecord10.1039/d3na00368j
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record